OncoSec Medical (ONCSQ) Competitors

Stock Analysis Chart Competitors Financials SEC Filings Trends

ONCSQ vs. LBPSW, ATNM, AEHAW, ALVOW, ACABW, ACABU, SUBL, CMRAW, EVLO, and FBIOP

Should you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include 4D pharma (LBPSW), Actinium Pharmaceuticals (ATNM), Aesther Healthcare Acquisition (AEHAW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), BioLingus (Cayman) (SUBL), Comera Life Sciences (CMRAW), Evelo Biosciences (EVLO), and Fortress Biotech (FBIOP). These companies are all part of the "pharmaceutical products" industry.

OncoSec Medical vs.

4D pharma (NASDAQ:LBPSW) and OncoSec Medical (NASDAQ:ONCSQ) are both manufacturing companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, community ranking, valuation, analyst recommendations, institutional ownership, earnings and risk.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
4D pharma
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
OncoSec Medical
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled 4D pharma'saverage media sentiment score.
Company Overall Sentiment
4D pharma Neutral
OncoSec Medical Neutral
: 4D pharma has higher revenue and earnings than OncoSec Medical.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
4D pharma $522K N/A N/A N/A N/A
OncoSec Medical N/A N/A -$34.18M N/A N/A
: Company Net Margins Return on Equity Return on Assets
4D pharma N/A N/A N/A
OncoSec Medical N/A N/A N/A
: 4D pharma and OncoSec Medical both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
4D pharma N/A N/A
OncoSec Medical N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
4D pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
OncoSec Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Overall Sentiment
4D pharma	Neutral
OncoSec Medical	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
4D pharma	$522K	N/A	N/A	N/A	N/A
OncoSec Medical	N/A	N/A	-$34.18M	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
4D pharma	N/A	N/A	N/A
OncoSec Medical	N/A	N/A	N/A

Company	Underperform	Outperform
4D pharma	N/A	N/A
OncoSec Medical	N/A	N/A

Summary

4D pharma beats OncoSec Medical on 1 of the 1 factors compared between the two stocks.

Ad Weiss Ratings

The next companies to potentially benefit thanks to Nvidia are …

Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.

Click here to learn more.

Get OncoSec Medical News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ONCSQ vs. The Competition

Export to Excel

Metric	OncoSec Medical	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$7.06B	$5.27B	$8.21B
Dividend Yield	N/A	2.81%	2.78%	3.96%
P/E Ratio	N/A	18.90	164.48	18.13
Price / Sales	N/A	294.97	2,079.25	89.14
Price / Cash	N/A	32.58	35.46	34.11
Price / Book	N/A	5.89	4.94	4.51
Net Income	-$34.18M	$147.89M	$111.50M	$216.29M

OncoSec Medical Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
LBPSW 4D pharma	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	$522,000.00	N/A
ATNM Actinium Pharmaceuticals	0 of 5 stars 0.00 / 5 stars	$7.85 -0.6%	N/A	N/A	$0.00	N/A	30	Analyst Forecast Short Interest ↑ News Coverage
AEHAW Aesther Healthcare Acquisition	0 of 5 stars 0.00 / 5 stars	$0.05 flat	N/A	-76.4%	$0.00	N/A	2	Gap Up
ALVOW Alvotech	0 of 5 stars 0.00 / 5 stars	$2.59 -3.4%	N/A	+70.4%	$0.00	$112.42M	4	Gap Up
ACABW Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$0.08 flat	N/A	N/A	$0.00	N/A	4	Positive News
ACABU Atlantic Coastal Acquisition Corp. II	0 of 5 stars 0.00 / 5 stars	$11.00 flat	N/A	+5.4%	$0.00	N/A	4	Positive News
SUBL BioLingus (Cayman)	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	N/A	N/A	High Trading Volume
CMRAW Comera Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.00 flat	N/A	N/A	$0.00	$1.00M	2
EVLO Evelo Biosciences	0 of 5 stars 0.00 / 5 stars	N/A	N/A	N/A	$0.00	N/A	120	Options Volume News Coverage High Trading Volume
FBIOP Fortress Biotech	0 of 5 stars 0.00 / 5 stars	$8.89 -7.2%	N/A	-47.6%	$0.00	$85.11M	170	Short Interest ↓ News Coverage High Trading Volume